Falsified Medicines Directive: A GDP Update

Subpage image
Loading

Falsified Medicines Directive: A GDP Update

07 Oct 2019
BUSINESS THEATRE
An update for stakeholders of FMD and the regulatory expectations.
Speakers
Peter Blundell, Senior GDP Medicines Inspector - MHRA

In association with

Pfizer

Supported by

Education Partners

Sponsored by

Charity Partner

Official Media Partner


CIG

Official Publications

Digital Media Partner


C+D

Natural Education Partner

Natural Pharmacy Business

Media partners